|
|
Genome-based Drug Discovery Market Research Reports
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Genome-based Drug Discovery Market, including, but not limited to latest business trend on: Pharmacogenomics; Lead Optimization; Bioinformatics; ADMET; Genomics; Proteomics; Transcriptomics; Metabonomics; Toxicogenomics.
We offer market research, industry forecasts, and business analysis in the Genome-based Drug Discovery Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Global Stem Cell and Advanced Technologies Market |
|
| Table of Contents Published: 2009/11 Published by: Markets and Markets |
| The healthcare industry has recently witnessed the adoption of many new technologies that increase the efficiency of various medical treatments. Minimally invasive surgery (MIS) is one of the most important developments among all such cutting-edge medical ... |
| DNA sequencing: technologies, markets and companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| This report briefly reviews development of sequencing technologies, current large and small sequencers as well as companies developing them. Companies developing software for analysis of sequencing data are listed. Selected academic institutes conducting ... |
| RNAi - technologies, markets and companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide RNAs termed siRNAs that are used in a sequence-specific manner to recognize and destroy ... |
| Proteomics - Technologies, Markets and Companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in the post-genomic era - the first decade of the 21st century. ... |
| Molecular Diagnostics - Technologies, Markets and Companies |
|
| Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech |
| 1This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. This includes several polym ... |
| Bioarrays for Life Science Research, Diagnostics and Drug R&D |
|
| Table of Contents Published: 2009/08 Published by: Takeda Pacific |
| This report discusses new bioarray products reaching the market including DNA and RNA products such as high-density arrays, tiling, copy number variation, SNPs, alternate splice variant arrays, ChIP-Chip, CpG island, DNA methylation, microRNA, sequence-ca ... |
| DNA Sequencing Equipment and Services Markets, 2nd Edition |
|
| Table of Contents Published: 2009/08 Published by: Kalorama Information |
| Since the last edition of Kalorama Information' s DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situati ... |
| Cell-Based Assays for Drug Discovery |
|
| Table of Contents Published: 2009/08 Published by: Trimark Publications |
| The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those applications th ... |
| MicroRNA Research Trends 2009 Market Report |
|
| Table of Contents Published: 2009/07 Published by: Select Biosciences, Ltd. |
| This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Research Market Trends. The focus of this report is to document the technical and commercial trends operative in the microRNA research space with emp ... |
| Proteomics: Technologies and Global Markets |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%. Proteomics equipment was valued at $4.1 billion in 2008 a ... |
| Pharmacogenomics: Delivering on the Promise |
|
| Table of Contents Published: 2009/06 Published by: Insight Pharma Reports |
| Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. ... |
| Next-Generation Sequencing: Solving the Genome |
|
| Table of Contents Published: 2009/06 Published by: Insight Pharma Reports |
| Next-generation sequencing (NGS) technologies are advancing in quality and applications diversity at a breathtaking pace. The market is diversifying strongly into labs without previous involvement in sequencing. ... |
| Pharmacogenomics for Clinical Use and in Drug Development |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ... |
| Genetics Bundle |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| The Genetics Bundlel includes 8 reports based on the genetic markets. ... |
| Companion Biomarkers in Drug Development |
|
| Table of Contents Published: 2009/04 Published by: Trimark Publications |
| This TriMark Publications report describes new biomarker technology platforms developed for the analyses of drug targets that are connected to the effectiveness of therapeutic agents in a clinical setting. ... |
| Strategic Analysis of U.S. MicroRNA Services Markets |
|
| Table of Contents Published: 2009/03 Published by: Frost & Sullivan |
| This research service provides a strategic analysis of the microRNA services market within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key challe ... |
| Bioinformatics Markets |
|
| Table of Contents Published: 2009/03 Published by: Trimark Publications |
| The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Publications beli ... |
| Toxicity Screening 2009 Market Report |
|
| Table of Contents Published: 2009/02 Published by: Select Biosciences, Ltd. |
| This is the latest and most up-to-date Toxicity Screening Market Analysis Report from Select Biosciences. This comprehensive report provides a qualitative and quantitative analysis of the toxicity screening space, market metrics, and thorough bottom-up ba ... |
| U.S. MicroRNA Markets |
|
| Table of Contents Published: 2008/12 Published by: Frost & Sullivan |
| This research service analyzes the market for microRNA products within the United States. The market was divided into the microRNA microarray, microRNA qRT-PCR, microRNA functional analysis and microRNA services segments. Each segment covers market driver ... |
| Biochips (Industry forecasts for 2012 & 2017) |
|
| Table of Contents Published: 2008/11 Published by: The Freedonia Group |
| The US market for biochip products and services will increase 9.9 percent per year to $2.5 billion in 2012. Microarrays will sustain the largest portion of product demand based on their consumable nature and expanding applications in drug discovery, life ... |
| Drug Discovery Technologies |
|
| Table of Contents Published: 2008/10 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Drug Discovery Technologies in Millions of US$. The specific technology types analyzed are Bioanalytical Instruments, High Throughput Screening (HTS), Biochip, Proteomics, Genomics, Bioinformatics, Pharmacoge ... |
| Microarray Markets |
|
| Table of Contents Published: 2008/09 Published by: Trimark Publications |
| A microarray is an arrangement of miniaturized test sites or spots on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological molecules--usually DNA or protein--which act as probes for a test sample applied to the ... |
| CNS Biomarkers Players, products and prospects |
|
| Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence |
| The CNS biomarker market represents one of the smallest segments of biomarkers in terms of revenue as relatively few CNS biomarkers are commercially available. In 2007, we estimate the CNS biomarker market accounted for less than 5% of biomarker revenues, ... |
| Cancer Biomarkers Players, products and prospects |
|
| Table of Contents Published: 2008/08 Published by: Espicom Business Intelligence |
| The cancer biomarker market represents one of the largest segments of biomarkers in terms of revenue. In 2007, the estimated cancer biomarker market accounted for around 55% of biomarker revenues at over US$3 billion, with the majority of revenues derived ... |
| DNA Sequencing: Emerging Technologies and Applications |
|
| Table of Contents Published: 2008/08 Published by: BCC Research |
| The study scope includes DNA sequencing technologies likely to be commercialized within the next five years. Sanger and next generation (non-Sanger sequencing) technologies are included. Each technology is analyzed to determine its market status, impact o ... |
| DNA Sequencing and PCR Markets |
|
| Table of Contents Published: 2008/07 Published by: Trimark Publications |
| The focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing. ... |
| Systems Biology: A Disruptive Technology |
|
| Table of Contents Published: 2008/05 Published by: Insight Pharma Reports |
| This report focuses on the current and future applications of Systems Biology in drug discovery, specifically in pinpointing optimal individual targets, and combinations of targets, to overcome metabolic pathway redundancies, leading to efficacious and sa ... |
| Genomics World Markets |
|
| Table of Contents Published: 2008/05 Published by: Trimark Publications |
| Genomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics. Virtually all of the major pharmaceutical houses ... |
|
|
|
View Cart
